secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001387131-23-002322
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals appoints R. Newcomb Stillwell to Board of Directors
-------------------------------------------------------------------------

- Appointed R. Newcomb Stillwell to Board, effective March 15, 2023.
- Stillwell was co-managing partner of Ropes & Gray Boston office with 38 years of corporate law experience.
- Board will award stock options with grant date fair value of $42,000, vesting at 2023 Annual Meeting.
- No related party transactions or arrangements in connection with appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000138713123002322/0001387131-23-002322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000138713123002322/tnxp_8k-022323.htm
  HTML page:      https://secwatch.observer/filing/0001387131-23-002322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer